Abstract
Pharmacologic infusion of activated protein C (APC) improves survival in severe sepsis, and platelet factor 4 (PF4) accelerates APC generation in a primate thrombin-infusion model. We now tested whether endogenous platelet PF4 content affectsAPC generation. Mice completely deficient in PF4 (mPF4 -/-) had impaired APC generation and survival after thrombin infusion, similar to the impairment seen in heterozygote protein C-deficient (PC+/-) mice. Transgenic mice overexpressing human PF4 (hPF4 +) had increased plasma APC generation. Overexpression of platelet PF4 compensated for the defect seen inPC+/- mice. In both a thrombin and a lipopolysaccharide (LPS) survival model, hPF4+ and PC +/-/hPF4+ mice had improved survival. Further, infusion of hPF4+ platelets improved survival of wild-type mice after an LPS challenge. These studies suggest that endogenous PF4 release may have biologic consequences for APC generation and survival in clinical sepsis. Infusions of PF4-rich platelets may be an effective strategy to improve outcome in this setting.
Original language | English (US) |
---|---|
Pages (from-to) | 1903-1905 |
Number of pages | 3 |
Journal | Blood |
Volume | 110 |
Issue number | 6 |
DOIs | |
State | Published - Sep 15 2007 |